Abstract
Antidepressant-related sexual dysfunction is a frequent adverse event caused by serotonergic activation that intensely affects quality of life and adherence in depressed patients. The dopamine system has multiple effects promoting sexual behavior, but no studies have been carried out to confirm dopaminergic changes involved in animal models after antidepressant use. Methods: The sexual behavior-related dopaminergic system in the rat was studied by comparing two different antidepressants and placebo for 28 days. The antidepressants used were paroxetine (a serotonergic antidepressant that causes highly frequent sexual dysfunction in humans) and agomelatine (a non-serotonergic antidepressant without associated sexual dysfunction). The tyrosine hydroxylase immunoreactivity (THI) in the substantia nigra pars compacta, the ventral tegmental area, the zona incerta, and the hypothalamic arcuate nucleus, as well as the dopaminergic projections to the striatum, hippocampus, cortex, and median eminence were analyzed. Results: The THI decreased significantly in the substantia nigra and ventral tegmental area after treatment with paroxetine, and the labeling was reduced drastically in the zona incerta and mediobasal hypothalamus. The immunoreactive axons in the target regions (striatum, cortex, hippocampus, and median eminence) almost disappeared only in the paroxetine-treated rats. Conversely, after treatment with agomelatine, a moderate reduction in immunoreactivity in the substantia nigra was found without appreciable modifications in the ventral tegmental area, zona incerta, and mediobasal hypothalamus. Nevertheless, no sexual or copulatory behavior was observed in any of the experimental or control groups. Conclusion: Paroxetine but not agomelatine was associated with important decreased activity in dopaminergic areas such as the substantia nigra and ventral tegmental areas that could be associated with sexual performance impairment in humans after antidepressant treatment.
Highlights
The dopaminergic (DA) and serotonergic (5-HT) modulatory systems are involved in regulating multiple functions through their abundant projections throughout the Central Nervous System (CNS)
Our aim in this research is to study the dopaminergic system in male Wistar rats, especially the nuclei where neurons are located in the brainstem (substantia nigra pars compacta (SNc) and ventral tegmental area (VTA)), diencephalon (zona incerta (ZI) and hypothalamic arcuate nucleus (Arc)), and their most relevant axonal projections in animals treated with paroxetine or agomelatine, which represents two different mechanisms of antidepressant action related to sexual adverse events
Images of the caudate-putamen, nucleus accumbens, and cortex were obtained from sections that correspond approximately with the coronal sections marked as Bregma 1.68–0.72 mm in the Paxinos and Watson atlas of the rat brain
Summary
The dopaminergic (DA) and serotonergic (5-HT) modulatory systems are involved in regulating multiple functions through their abundant projections throughout the Central Nervous System (CNS). Our aim in this research is to study the dopaminergic system in male Wistar rats, especially the nuclei where neurons are located in the brainstem (substantia nigra pars compacta (SNc) and VTA), diencephalon (zona incerta (ZI) and hypothalamic arcuate nucleus (Arc)), and their most relevant axonal projections (striatum, hippocampus, hypothalamus, and cortex) in animals treated with paroxetine or agomelatine, which represents two different mechanisms of antidepressant action related to sexual adverse events. We will compare their effects on immunoreactivity to tyrosine hydroxylase, the rate-limiting enzyme of dopamine synthesis. We hypothesize that if the dopaminergic system is involved in sexual dysfunction caused by SSRIs, different antidepressant treatments will differentially modify TH immunoreactivity
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.